Financhill
Back

Cue Biopharma Stock Predictions

Cue Biopharma Stock Forecast

  • Is Cue Biopharma Stock Undervalued?
    The current Cue Biopharma [CUE] share price is $1.03. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Cue Biopharma Stock Go Up Next Year?

Data Unavailable

Cue Biopharma Stock Rating

Data Unavailable

Cue Biopharma Stock Price History

Is CUE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cuebiopharma.com

52-Week Data

52-Week High:
3.25
52-Week Low:
0.45

Prediction Charts

Market Cap:
65.25M
Price in USD:
1.03
Volume:
486.48K
Beta:
1.69

Technical Analysis

SMA50:
1.17
SMA100:
0.96
SMA200:
1.38
52-Wk Change:
-56.72%

Stock Predictions

  • Is Cue Biopharma stock public?
    Yes, Cue Biopharma is a publicly traded company.
  • What is the Cue Biopharma stock quote today?
    The Cue Biopharma stock price is 1.03 USD today.
  • How to buy Cue Biopharma stock online?
    You can buy Cue Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 1.51 1.49 1.64 1.45
Nov-5 1.48 1.71 1.74 1.32
Nov-6 1.76 1.65 1.89 1.56
Nov-7 1.65 1.78 1.90 1.59
Nov-8 1.79 1.72 1.87 1.64
Nov-11 1.70 1.86 1.99 1.69
Nov-12 1.88 1.69 1.92 1.61
Nov-13 1.71 1.50 1.84 1.46
Nov-14 1.58 1.50 1.60 1.45
Nov-15 1.50 1.25 1.56 1.24
Nov-18 1.25 1.10 1.37 1.05
Nov-19 1.10 1.08 1.19 1.04
Nov-20 1.11 1.09 1.17 1.05
Nov-21 1.09 1.03 1.10 1.02

Cue Biopharma Earnings

Data Unavailable

Cue Biopharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

* Cue Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.